Epivir-HBV Interactions
There are 48 drugs known to interact with Epivir-HBV (lamivudine), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 14 are major, 33 are moderate, and 1 is minor.
- View all 48 medications that may interact with Epivir-HBV
- View Epivir-HBV alcohol/food interactions (1)
- View Epivir-HBV disease interactions (4)
Most frequently checked interactions
View interaction reports for Epivir-HBV (lamivudine) and the medicines listed below.
- abacavir
- Adriamycin (doxorubicin)
- Alimta (pemetrexed)
- allopurinol
- azathioprine
- Baraclude (entecavir)
- Clozaril (clozapine)
- Crestor (rosuvastatin)
- Crixivan (indinavir)
- Depakote Sprinkles (divalproex sodium)
- Dexilant (dexlansoprazole)
- Diovan HCT (hydrochlorothiazide / valsartan)
- Entyvio (vedolizumab)
- Exelon (rivastigmine)
- Feiba (anti-inhibitor coagulant complex)
- furosemide
- Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide)
- Hepsera (adefovir)
- Humira (adalimumab)
- Inderal (propranolol)
- Invirase (saquinavir)
- Isentress (raltegravir)
- multivitamin
- Norvir (ritonavir)
- Nydrazid (isoniazid)
- Prezista (darunavir)
- Prograf (tacrolimus)
- Tyzeka (telbivudine)
- Videx (didanosine)
- Viread (tenofovir)
Epivir-HBV alcohol/food interactions
There is 1 alcohol/food interaction with Epivir-HBV (lamivudine).
Epivir-HBV disease interactions
There are 4 disease interactions with Epivir-HBV (lamivudine) which include:
More about Epivir-HBV (lamivudine)
- Epivir-HBV consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.